Skip to Content

Guaifenesin / potassium guaiacolsulfonate Pregnancy and Breastfeeding Warnings

Guaifenesin / potassium guaiacolsulfonate is also known as: Allfen, Cypex-LA, Humibid LA

Guaifenesin / potassium guaiacolsulfonate Pregnancy Warnings

Guaifenesin-potassium guaiacolsulfonate has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Guaifenesin-potassium guaiacolsulfonate is only recommended for use during pregnancy when benefit outweighs risk.

See references

Guaifenesin / potassium guaiacolsulfonate Breastfeeding Warnings

There are no data on the excretion of guaifenesin-potassium guaiacolsulfonate into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Humibid L.A. (guaifenesin-potassium guaiacolsulfonate)." Carolina Pharmaceuticals Inc, Cary, NC.

References for breastfeeding information

  1. "Product Information. Humibid L.A. (guaifenesin-potassium guaiacolsulfonate)." Carolina Pharmaceuticals Inc, Cary, NC.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide